Other interesting therapeutic perspective is represented by targeting of the β-catenin destruction complex (APC, Axin, CK1, and GSK3β) with the aim to induce the inactivation of Wnt signaling in HCC. This evidence concerns the gene AXIN1 and hepatocellular carcinoma.